Anti‐tumor effects of PIM / PI 3K/ mTOR triple kinase inhibitor IBL ‐302 in neuroblastoma

Corrigendum9 January 2020Open Access Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma Sofie Mohlin Sofie Mohlin orcid.org/0000-0002-2458-3963 Search for more papers by this author Karin Hansson Karin Hansson Search for more papers by this author Katarzyna Radke Katarzyna Radke Search for more papers by this author Sonia Martinez Sonia Martinez orcid.org/0000-0003-2230-7794 Search for more papers by this author Carmen Blanco-Aparicio Carmen Blanco-Aparicio Search for more papers by this author Cristian Garcia-Ruiz Cristian Garcia-Ruiz orcid.org/0000-0003-2914-7914 Search for more papers by this author Charlotte Welinder Charlotte Welinder Search for more papers by this author Javanshir Esfandyari Javanshir Esfandyari Search for more papers by this author Michael O'Neill Michael O'Neill Search for more papers by this author Joaquin Pastor Joaquin Pastor Search for more papers by this author Kristoffer von Stedingk Kristoffer von Stedingk Search for more papers by this author Daniel Bexell Daniel Bexell orcid.org/0000-0001-9426-9550 Search for more papers by this author Sofie Mohlin Sofie Mohlin orcid.org/0000-0002-2458-3963 Search for more papers by this author Karin Hansson Karin Hansson Search for more papers by this author Katarzyna Radke Katarzyna Radke Search for more papers by this author Sonia Martinez Sonia Martinez orcid.org/0000-0003-2230-7794 Search for more papers by this author Carmen Blanco-Aparicio Carmen Blanco-Aparicio Search for more papers by this author Cristian Garcia-Ruiz Cristian Garcia-Ruiz orcid.org/0000-0003-2914-7914 Search for more papers by this author Charlotte Welinder Charlotte Welinder Search for more papers by this author Javanshir Esfandyari Javanshir Esfandyari Search for more papers by this author Michael O'Neill Michael O'Neill Search for more papers by this author Joaquin Pastor Joaquin Pastor Search for more papers by this author Kristoffer von Stedingk Kristoffer von Stedingk Search for more papers by this author Daniel Bexell Daniel Bexell orcid.org/0000-0001-9426-9550 Search for more papers by this author Author Information Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco-Aparicio, Cristian Garcia-Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer Stedingk and Daniel Bexell EMBO Mol Med (2020)12:e11749https://doi.org/10.15252/emmm.201911749 This article corrects the following: Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma16 July 2019 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info The authors regret making a spelling error in Carmen Blanco-Aparicio's name. The spelling is herewith corrected. Next ArticlePrevious Article Read MoreAbout the coverClose modalView large imageVolume 12,Issue 1,09 January 2020This month's cover highlights the article Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis by JinbeomHeo, Dong‐Myung Shin, and colleagues, at the Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Korea. Opal multiplex immunofluorescence image of human bladder tumor showing bladder cancer cells labeled with Thr177 phosphorylated TFCP2L1 in yellow, CDK1 in cyan, CD44 in orange, SALL4 in red, and cytokeratin in green. Nuclei were counterstained with DAPI in blue. Scientific image by JinbeomHeo, who captured the image of Opal multiplex immunofluorescence staining of human bladder tumors. Volume 12Issue 19 January 2020In this issue RelatedDetailsLoading ...